SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stem Cell Research
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SnowShredder who wrote (70)1/6/2005 6:42:37 PM
From: BulbaMan  Read Replies (1) of 495
 
Saneron CCEL Therapeutics, mentioned in the last paragraph, is 43% owned by Cryo-Cell (CCEL). CCEL is primarily in the umbilical cord stem cell storage business and is making money. IMHO, their research arm, Saneron, increases CCEL's potential.
FD: I own CCEL and am quite bullish on the stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News